CD14 and neoplasm: The most upregulated markers in tumour samples were HLADR (26.54-fold increase, mean LFC = 4.73 ± 0.27; p < 0.0001, 95% CI = 3.88 to 5.58), CD68 (29.82-fold increase, mean LFC = 4.90 ± 0.26; p < 0.0001, 95% CI = 4.23 to 5.57) and CD14 (16.61-fold increase, mean LFC = 4.05 ± 0.28; p < 0.0001, 95% CI = 3.37 to 4.74), correlating to increased monocyte and macrophage/microglia infiltration (CD68 and CD14), and antigen presentation (HLADR).